Genertec Universal Medical Group Company Limited
Genertec Universal Medical Group Company Limited, together with its subsidiaries, provides financing, advisory, and medical services in the People's Republic of China. It operates through two segments, Finance Business and Healthcare Business. The Finance Business segment offers direct finance leasing; sale and leaseback; accounts receivable factoring; operating leases; and advisory services. Its… Read more
Genertec Universal Medical Group Company Limited (5UM) - Total Liabilities
Latest total liabilities as of June 2025: €62.90 Billion EUR
Based on the latest financial reports, Genertec Universal Medical Group Company Limited (5UM) has total liabilities worth €62.90 Billion EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Genertec Universal Medical Group Company Limited - Total Liabilities Trend (2016–2024)
This chart illustrates how Genertec Universal Medical Group Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Genertec Universal Medical Group Company Limited Competitors by Total Liabilities
The table below lists competitors of Genertec Universal Medical Group Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grupo Simec S.A.B. de C.V
MX:SIMECB
|
Mexico | MX$11.40 Billion |
|
Qingdao Haier Biomedical Co Ltd
SHG:688139
|
China | CN¥1.05 Billion |
|
Vestjysk Bank A/S
CO:VJBA
|
Denmark | Dkr43.37 Billion |
|
Eris Lifesciences Limited
NSE:ERIS
|
India | ₹36.56 Billion |
|
Nine Dragons Paper (Holdings) Limited
PINK:NDGPF
|
USA | $99.29 Billion |
|
Angang Steel Company Limited
PINK:ANGGF
|
USA | $50.68 Billion |
|
CTT - Correios De Portugal S.A
PINK:CTTOF
|
USA | $5.62 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Genertec Universal Medical Group Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Genertec Universal Medical Group Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Genertec Universal Medical Group Company Limited (2016–2024)
The table below shows the annual total liabilities of Genertec Universal Medical Group Company Limited from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €63.16 Billion | +5.31% |
| 2023-12-31 | €59.98 Billion | +4.91% |
| 2022-12-31 | €57.17 Billion | +9.36% |
| 2021-12-31 | €52.28 Billion | +12.31% |
| 2020-12-31 | €46.55 Billion | +4.82% |
| 2019-12-31 | €44.41 Billion | +20.01% |
| 2018-12-31 | €37.00 Billion | +22.26% |
| 2017-12-31 | €30.26 Billion | +35.16% |
| 2016-12-31 | €22.39 Billion | -- |